Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.
2.

Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control.

Petrongari MG, Landoni V, Saracino B, Gomellini S, Arcangeli S, Iaccarino G, Pinnarò P, Arcangeli G, Strigari L.

J Exp Clin Cancer Res. 2013 Dec 13;32:103. doi: 10.1186/1756-9966-32-103.

PMID:
24330467
[PubMed - in process]
Free PMC Article
3.

Bladder cancer after radiotherapy for prostate cancer.

Suriano F, Altobelli E, Sergi F, Buscarini M.

Rev Urol. 2013;15(3):108-12. Review.

PMID:
24223022
[PubMed]
Free PMC Article
4.

Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre.

Sia J, Joon DL, Viotto A, Mantle C, Quong G, Rolfo A, Wada M, Anderson N, Rolfo M, Khoo V.

Cancers (Basel). 2011 Sep 1;3(3):3419-31. doi: 10.3390/cancers3033419.

PMID:
24212961
[PubMed]
Free PMC Article
5.

Real-time prostate motion assessment: image-guidance and the temporal dependence of intra-fraction motion.

Cramer AK, Haile AG, Ognjenovic S, Doshi TS, Reilly WM, Rubinstein KE, Nabavizadeh N, Nguyen T, Meng LZ, Fuss M, Tanyi JA, Hung AY.

BMC Med Phys. 2013 Sep 23;13(1):4. doi: 10.1186/1756-6649-13-4.

PMID:
24059584
[PubMed]
Free PMC Article
6.

A study on rectal dose measurement in phantom and in vivo using Gafchromic EBT3 film in IMRT and CyberKnife treatments of carcinoma of prostate.

Ganapathy K, Kurup PG, Murali V, Muthukumaran M, Subramanian SB, Velmurugan J.

J Med Phys. 2013 Jul;38(3):132-8. doi: 10.4103/0971-6203.116372.

PMID:
24049320
[PubMed]
Free PMC Article
7.

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells.

Xiao W, Graham PH, Hao J, Chang L, Ni J, Power CA, Dong Q, Kearsley JH, Li Y.

PLoS One. 2013 Aug 26;8(8):e74253. doi: 10.1371/journal.pone.0074253. eCollection 2013.

PMID:
23991216
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer.

Goineau A, Marchand V, Rigaud J, Bourdin S, Rio E, Campion L, Bonnaud-Antignac A, Mahé MA, Supiot S.

Radiat Oncol. 2013 Mar 6;8:53. doi: 10.1186/1748-717X-8-53.

PMID:
23510499
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Stereotactic body radiation therapy for the primary treatment of localized prostate cancer.

Oliai C, Lanciano R, Sprandio B, Yang J, Lamond J, Arrigo S, Good M, Mooreville M, Garber B, Brady LW.

J Radiat Oncol. 2013 Mar;2(1):63-70. Epub 2012 Sep 12.

PMID:
23504305
[PubMed]
Free PMC Article
10.

Clinical controversies: proton therapy for prostate cancer.

Mouw KW, Trofimov A, Zietman AL, Efstathiou JA.

Semin Radiat Oncol. 2013 Apr;23(2):109-14. doi: 10.1016/j.semradonc.2012.11.009. Review.

PMID:
23473687
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.

Eckert F, Alloussi S, Paulsen F, Bamberg M, Zips D, Spillner P, Gani C, Kramer U, Thorwarth D, Schilling D, Müller AC.

BMC Cancer. 2013 Jan 22;13:27. doi: 10.1186/1471-2407-13-27.

PMID:
23336502
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The clinical case for proton beam therapy.

Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB.

Radiat Oncol. 2012 Oct 22;7:174. doi: 10.1186/1748-717X-7-174. Review.

PMID:
23083010
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.

Azelie C, Gauthier M, Mirjolet C, Cormier L, Martin E, Peignaux-Casasnovas K, Truc G, Chamois J, Maingon P, Créhange G.

Radiat Oncol. 2012 Sep 17;7:158. doi: 10.1186/1748-717X-7-158.

PMID:
22978763
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer.

Parthan A, Pruttivarasin N, Davies D, Taylor DC, Pawar V, Bijlani A, Lich KH, Chen RC.

Front Oncol. 2012 Aug 20;2:81. doi: 10.3389/fonc.2012.00081. eCollection 2012.

PMID:
22934286
[PubMed]
Free PMC Article
15.

Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer.

Johansson S, Aström L, Sandin F, Isacsson U, Montelius A, Turesson I.

Prostate Cancer. 2012;2012:654861. doi: 10.1155/2012/654861. Epub 2012 Jul 8.

PMID:
22848840
[PubMed]
Free PMC Article
16.

Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.

Takeda K, Takai Y, Narazaki K, Mitsuya M, Umezawa R, Kadoya N, Fujita Y, Sugawara T, Kubozono M, Shimizu E, Abe K, Shirata Y, Ishikawa Y, Yamamoto T, Kozumi M, Dobashi S, Matsushita H, Chida K, Ishidoya S, Arai Y, Jingu K, Yamada S.

Radiat Oncol. 2012 Jul 6;7:105. doi: 10.1186/1748-717X-7-105.

PMID:
22770471
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?

Katz AJ, Santoro M, Ashley R, Diblasio F.

Front Oncol. 2011 Dec 5;1:49. doi: 10.3389/fonc.2011.00049. eCollection 2011.

PMID:
22655249
[PubMed]
Free PMC Article
18.

Radiation treatment for patients with intermediate-risk prostate cancer.

Greene DE, Mayadev JS, Valicenti RK.

Ther Adv Urol. 2012 Jun;4(3):113-24. doi: 10.1177/1756287212442977.

PMID:
22654963
[PubMed]
Free PMC Article
19.

The current role of androgen deprivation in patients undergoing dose-escalated external beam radiation therapy for clinically localized prostate cancer.

Smith MJ, Akhtar NH, Tagawa ST.

Prostate Cancer. 2012;2012:280278. doi: 10.1155/2012/280278. Epub 2012 Apr 24.

PMID:
22619727
[PubMed]
Free PMC Article
20.

Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer.

Hunter GK, Reddy CA, Klein EA, Kupelian P, Angermeier K, Ulchaker J, Chehade N, Altman A, Ciezki JP.

Prostate Cancer. 2012;2012:853487. doi: 10.1155/2012/853487. Epub 2012 Apr 11.

PMID:
22577562
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk